secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cytosorbents Corp (CTSO)
CIK:        0001175151
Form:       8-K
Filed at:   2024-10-01T23:59:59+00:00
Accession:  0001104659-24-105024
Event type: other_material
Sentiment:  neutral
Materiality: 0.80
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CytoSorbents authorizes up to $20M ATM equity offering of common stock
----------------------------------------------------------------------

- Company authorized offer and sale of up to $20M common stock under Open Market Sale Agreement with Jefferies LLC.
- Registration statement on Form S-3 (No. 333-281062) declared effective by SEC on September 30, 2024.
- Legal opinion of Morgan Lewis & Bockius LLP on legality of issuance filed as Exhibit 5.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1175151/000110465924105024/0001104659-24-105024-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1175151/000110465924105024/tm2425360d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-105024

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer